Fred Kurland has been appointed vice president, finance and chief financial officer at Xoma, Ltd. Mr. Kurland will be responsible for directing the company’s financial strategy, accounting, financial planning and investor relations functions.     “Fred is a seasoned financial executive with over 30 years of experience in biotechnology and pharmaceutical companies including Aviron/MedImmune, Protein Design Labs and Syntex/Roche,” said Steve Engle, chairman and chief executive...